Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
(OP:
BMNDF
)
N/A
UNCHANGED
Last Price
Updated: 3:14 PM EDT, Apr 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
0.1100
Today's Range
N/A - N/A
52wk Range
0.0887 - 0.5298
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Biomind Labs Completes the Development of the First 5-MeO-DMT Organic Synthesis Scheme for Pharmaceutical Applications
September 14, 2023
From
Biomind Labs Inc.
Via
Business Wire
Cybin, GH Research Among Top Psychedelic Movers Of Today
January 27, 2023
Via
Benzinga
Performance
More News
Read More
Psychedelic Stock Gainers And Losers From January 26, 2023
January 26, 2023
Via
Benzinga
Biomind Labs, Intelgenx Technologies Among Top Psychedelic Movers Of Today
January 25, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From January 24, 2023
January 24, 2023
Via
Benzinga
New Sublingual Psychedelic Drug Candidate Created For Depression And Anxiety In Alzheimer's
December 29, 2022
Via
Benzinga
Psychedelic Stock Gainers And Losers From November 22, 2022
November 22, 2022
Via
Benzinga
Psyched: Musk's Empathy Tweets, Psychedelics In Congress, Oregon's Opt-Outs, MAPS' MDMA Trial And More
November 21, 2022
Via
Benzinga
Psychedelic Stock Gainers And Losers From November 21, 2022
November 21, 2022
Via
Benzinga
Biomind Labs, ATAI Life Sciences Among Top Psychedelic Movers Of Today
November 18, 2022
Via
Benzinga
Revive Therapeutics, GH Research Among Top Psychedelic Movers Of Today
November 17, 2022
Via
Benzinga
Psychedelic Stock Gainers And Losers From November 16, 2022
November 16, 2022
Via
Benzinga
GH Research, Seelos Therapeutics Among Top Psychedelic Movers Of Today
November 15, 2022
Via
Benzinga
Biomind Labs: Q3 Financials & FDA Approval For New Chemical Entity Targeting Treatment-Resistant Depression
November 15, 2022
Via
Benzinga
Compass Pathways, Mind Medicine Among Top Psychedelic Movers Of Today
November 10, 2022
Via
Benzinga
Seelos Therapeutics, GH Research Among Top Psychedelic Movers Of Today
November 09, 2022
Via
Benzinga
Psychedelic Stock Gainers And Losers From November 8, 2022
November 08, 2022
Via
Benzinga
Compass Pathways, Allied Among Top Psychedelic Movers Of Today
November 07, 2022
Via
Benzinga
Next-Gen Psychedelic Delivers Promising Results For Treatment-Resistant Depression In Phase 2 Clinical Trial
November 04, 2022
Via
Benzinga
Psychedelic Stock Gainers And Losers From November 3, 2022
November 03, 2022
Via
Benzinga
Compass Pathways, Small Pharma Among Top Psychedelic Movers Of Today
November 02, 2022
Via
Benzinga
Revive Therapeutics, Small Pharma Among Top Psychedelic Movers Of Today
October 27, 2022
Via
Benzinga
Psychedelic Stock Gainers And Losers From October 26, 2022
October 26, 2022
Via
Benzinga
Psychedelic Stock Gainers And Losers From October 25, 2022
October 25, 2022
Via
Benzinga
Allied, Small Pharma Among Top Psychedelic Movers Of Today
October 21, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.